Adhesion Dependent Signalling in the Tumour Microenvironment: The Future of Drug Targetting

E-ISSN： 1873-4286|12|22|2833-2848

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.22, 2006-08, pp. : 2833-2848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypoxia signalling in tumour angiogenesis

By Knies U.E. Harris A.L.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 3, 2000-06 ,pp. : 361-375

Informa Healthcare

Access to resources Recommend Favorite

DNA Base Excision Repair: The Achilles' Heel of Tumour Cells and their Microenvironment?

Current Pharmaceutical Design, Vol. 23, Iss. 32, 2017-12 ,pp. : 4758-4772

Bentham Science Publishers

Access to resources Recommend Favorite

Estrogen Receptor Signalling: Bases for Drug Actions

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 3, 2005-09 ,pp. : 305-314

Bentham Science Publishers

Access to resources Recommend Favorite

The future of plant drug discovery

By Littleton John

Expert Opinion on Drug Discovery, Vol. 2, Iss. 5, 2007-05 ,pp. : 673-683

Informa Healthcare

Access to resources Recommend Favorite

Squalamine: A Polyvalent Drug of the Future?

Current Cancer Drug Targets, Vol. 5, Iss. 4, 2005-06 ,pp. : 267-272

Bentham Science Publishers

Access to resources Recommend Favorite